29 results on '"Siebzehnrubl, Florian A."'
Search Results
2. Zeb1 modulates hematopoietic stem cell fates required for suppressing acute myeloid leukemia
- Author
-
Almotiri, Alhomidi, Alzahrani, Hamed, Menendez-Gonzalez, Juan Bautista, Abdelfattah, Ali, Alotaibi, Badi, Saleh, Lubaid, Greene, Adelle, Georgiou, Mia, Gibbs, Alex, Alsayari, Amani, Taha, Sarab, Thomas, Leigh-anne, Shah, Dhruv, Edkins, Sarah, Giles, Peter, Stemmler, Marc P., Brabletz, Simone, Brabletz, Thomas, Boyd, Ashleigh S., Siebzehnrubl, Florian A., and Rodrigues, Neil P.
- Subjects
Gene expression -- Health aspects ,Stem cells -- Genetic aspects -- Health aspects ,Cancer cells -- Genetic aspects -- Health aspects ,Transcription factors -- Health aspects ,Health care industry - Abstract
Zeb1, a zinc finger E-box binding homeobox epithelial-mesenchymal transition (EMT) transcription factor, confers properties of 'sternness,' such as self-renewal, in cancer. Yet little is known about the function of Zeb1 in adult stem cells. Here, we used the hematopoietic system as a well-established paradigm of stem cell biology to evaluate Zeb1-mediated regulation of adult stem cells. We employed a conditional genetic approach using the Mx1- Cre system to specifically knock out (KO) Zeb1 in adult hematopoietic stem cells (HSCs) and their downstream progeny. Acute genetic deletion of Zeb1 led to rapid-onset thymic atrophy and apoptosis-driven loss of thymocytes and T cells. A profound cell-autonomous self-renewal defect and multilineage differentiation block were observed in Zeb1-KO HSCs. Loss of Zeb1 in HSCs activated transcriptional programs of deregulated HSC maintenance and multilineage differentiation genes and of cell polarity consisting of cytoskeleton-, lipid metabolism/lipid membrane-, and cell adhesion-related genes. Notably, epithelial cell adhesion molecule (EpCAM) expression was prodigiously upregulated in Zeb1-KO HSCs, which correlated with enhanced cell survival, diminished mitochondrial metabolism, ribosome biogenesis, and differentiation capacity and an activated transcriptomic signature associated with acute myeloid leukemia (AML) signaling. ZEB1 expression was downregulated in AML patients, and Zeb1 KO in the malignant counterparts of HSCs--leukemic stem cells (LSCs)--accelerated MLL-AF9- and Meis1a/Hoxa9-driven AML progression, implicating Zeb1 as a tumor suppressor in AML LSCs. Thus, Zeb1 acts as a transcriptional regulator in hematopoiesis, critically coordinating HSC self-renewal, apoptotic, and multilineage differentiation fates required to suppress leukemic potential in AML., Introduction Epithelial-mesenchymal transition (EMT) is a complex process that organizes specific changes in cellular fate and phenotype and is usually accompanied by loss of cell polarity and adhesion and increased [...]
- Published
- 2021
- Full Text
- View/download PDF
3. Transcriptional control of embryonic and adult neural progenitor activity.
- Author
-
Singh, Niharika, Siebzehnrubl, Florian A., and Martinez-Garay, Isabel
- Subjects
GENETIC transcription regulation ,TRANSCRIPTION factors ,CEREBRAL cortex ,ADULTS ,CELL differentiation - Abstract
Neural precursors generate neurons in the embryonic brain and in restricted niches of the adult brain in a process called neurogenesis. The precise control of cell proliferation and differentiation in time and space required for neurogenesis depends on sophisticated orchestration of gene transcription in neural precursor cells. Much progress has been made in understanding the transcriptional regulation of neurogenesis, which relies on dose- and context-dependent expression of specific transcription factors that regulate the maintenance and proliferation of neural progenitors, followed by their differentiation into lineage-specified cells. Here, we review some of the most widely studied neurogenic transcription factors in the embryonic cortex and neurogenic niches in the adult brain. We compare functions of these transcription factors in embryonic and adult neurogenesis, highlighting biochemical, developmental, and cell biological properties. Our goal is to present an overview of transcriptional regulation underlying neurogenesis in the developing cerebral cortex and in the adult brain. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
4. Engineering Adenoviral Vectors with Improved GBM Selectivity.
- Author
-
Bates, Emily A., Lovatt, Charlotte, Plein, Alice R., Davies, James A., Siebzehnrubl, Florian A., and Parker, Alan L.
- Subjects
TRANSGENE expression ,GLIOBLASTOMA multiforme ,CELL receptors ,REPORTER genes ,BRAIN cancer ,CD46 antigen ,DEEP brain stimulation - Abstract
Glioblastoma (GBM) is the most common and aggressive adult brain cancer with an average survival rate of around 15 months in patients receiving standard treatment. Oncolytic adenovirus expressing therapeutic transgenes represent a promising alternative treatment for GBM. Of the many human adenoviral serotypes described to date, adenovirus 5 (HAdV-C5) has been the most utilised clinically and experimentally. However, the use of Ad5 as an anti-cancer agent may be hampered by naturally high seroprevalence rates to HAdV-C5 coupled with the infection of healthy cells via native receptors. To explore whether alternative natural adenoviral tropisms are better suited to GBM therapeutics, we pseudotyped an HAdV-C5-based platform using the fibre knob protein from alternative serotypes. We demonstrate that the adenoviral entry receptor coxsackie, adenovirus receptor (CAR) and CD46 are highly expressed by both GBM and healthy brain tissue, whereas Desmoglein 2 (DSG2) is expressed at a low level in GBM. We demonstrate that adenoviral pseudotypes, engaging CAR, CD46 and DSG2, effectively transduce GBM cells. However, the presence of these receptors on non-transformed cells presents the possibility of off-target effects and therapeutic transgene expression in healthy cells. To enhance the specificity of transgene expression to GBM, we assessed the potential for tumour-specific promoters hTERT and survivin to drive reporter gene expression selectively in GBM cell lines. We demonstrate tight GBM-specific transgene expression using these constructs, indicating that the combination of pseudotyping and tumour-specific promoter approaches may enable the development of efficacious therapies better suited to GBM. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. Low Proliferation and Differentiation Capacities of Adult Hippocampal Stem Cells Correlate with Memory Dysfunction in Humans
- Author
-
Coras, Roland, Siebzehnrubl, Florian A., and Pauli, Elisabeth
- Abstract
The hippocampal dentate gyrus maintains its capacity to generate new neurons throughout life. In animal models, hippocampal neurogenesis is increased by cognitive tasks, and experimental ablation of neurogenesis disrupts specific modalities of learning and memory. In humans, the impact of neurogenesis on cognition remains unclear. Here, we assessed the neurogenic potential in the human hippocampal dentate gyrus by isolating adult human neural stem cells from 23 surgical "en bloc" hippocampus resections. After proliferation of the progenitor cell pool "in vitro" we identified two distinct patterns. Adult human neural stem cells with a high proliferation capacity were obtained in 11 patients. Most of the cells in the high proliferation capacity cultures were capable of neuronal differentiation (53 plus or minus 13% of "in vitro" cell population). A low proliferation capacity was observed in 12 specimens, and only few cells differentiated into neurons (4 plus or minus 2%). This was reflected by reduced numbers of proliferating cells "in vivo" as well as granule cells immunoreactive for doublecortin, brain-derived neurotrophic factor and cyclin-dependent kinase 5 in the low proliferation capacity group. High and low proliferation capacity groups differed dramatically in declarative memory tasks. Patients with high proliferation capacity stem cells had a normal memory performance prior to epilepsy surgery, while patients with low proliferation capacity stem cells showed severe learning and memory impairment. Histopathological examination revealed a highly significant correlation between granule cell loss in the dentate gyrus and the same patient's regenerative capacity "in vitro" (r = 0.813; P less than 0.001; linear regression: R[superscript 2][subscript adjusted] = 0.635), as well as the same patient's ability to store and recall new memories (r = 0.966; P = 0.001; linear regression: R[superscript 2][subscript adjusted] = 0.9). Our results suggest that encoding new memories is related to the regenerative capacity of the hippocampus in the human brain.
- Published
- 2010
- Full Text
- View/download PDF
6. Detection of primary cilia in human glioblastoma
- Author
-
Sarkisian, Matthew R., Siebzehnrubl, Dorit, Hoang-Minh, Lan, Deleyrolle, Loic, Silver, Daniel J., Siebzehnrubl, Florian A., Guadiana, Sarah M., Srivinasan, Gayathri, Semple-Rowland, Susan, Harrison, Jeffrey K., Steindler, Dennis A., and Reynolds, Brent A.
- Published
- 2014
- Full Text
- View/download PDF
7. ZEB1 Promotes Invasion in Human Fetal Neural Stem Cells and Hypoxic Glioma Neurospheres
- Author
-
Kahlert, Ulf D., Suwala, Abigail K., Raabe, Eric H., Siebzehnrubl, Florian A., Suarez, Maria J., Orr, Brent A., Bar, Eli E., Maciaczyk, Jaroslaw, and Eberhart, Charles G.
- Published
- 2015
- Full Text
- View/download PDF
8. Nuclear β-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas
- Author
-
Buslei, Rolf, Hölsken, Annett, Hofmann, Bernd, Kreutzer, Jürgen, Siebzehnrubl, Florian, Hans, Volkmar, Oppel, Falk, Buchfelder, Michael, Fahlbusch, Rudolf, and Blümcke, Ingmar
- Published
- 2007
- Full Text
- View/download PDF
9. Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain precursor cells
- Author
-
Siebzehnrubl, Florian A., Buslei, Rolf, Eyupoglu, Ilker Y., Seufert, Sebastian, Hahnen, Eric, and Blumcke, Ingmar
- Published
- 2007
- Full Text
- View/download PDF
10. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance
- Author
-
Siebzehnrubl, Florian A., Silver, Daniel J., Tugertimur, Bugra, Deleyrolle, Loic P., Siebzehnrubl, Dorit, Sarkisian, Matthew R., Devers, Kelly G., Yachnis, Antony T., Kupper, Marius D., Neal, Daniel, Nabilsi, Nancy H., Kladde, Michael P., Suslov, Oleg, Brabletz, Simone, Brabletz, Thomas, Reynolds, Brent A., and Steindler, Dennis A.
- Published
- 2013
- Full Text
- View/download PDF
11. Evidence for label-retaining tumour-initiating cells in human glioblastoma
- Author
-
Deleyrolle, Loic P., Harding, Angus, Cato, Kathleen, Siebzehnrubl, Florian A., Rahman, Maryam, Azari, Hassan, Olson, Sarah, Gabrielli, Brian, Osborne, Geoffrey, Vescovi, Angelo, and Reynolds, Brent A.
- Published
- 2011
- Full Text
- View/download PDF
12. Low proliferation and differentiation capacities of adult hippocampal stem cells correlate with memory dysfunction in humans
- Author
-
Coras, Roland, Siebzehnrubl, Florian A., Pauli, Elisabeth, Huttner, Hagen B., Njunting, Marleisje, Kobow, Katja, Villmann, Carmen, Hahnen, Eric, Neuhuber, Winfried, Weigel, Daniel, Buchfelder, Michael, Stefan, Hermann, Beck, Heinz, Steindler, Dennis A., and Blümcke, Ingmar
- Published
- 2010
- Full Text
- View/download PDF
13. Spontaneous In Vitro Transformation of Adult Neural Precursors into Stem-Like Cancer Cells
- Author
-
Siebzehnrubl, Florian A., Jeske, Ina, Müller, Dorit, Buslei, Rolf, Coras, Roland, Hahnen, Eric, Huttner, Hagen B., Corbeil, Denis, Kaesbauer, Johanna, Appl, Thomas, von Hörsten, Stephan, and Blümcke, Ingmar
- Published
- 2009
- Full Text
- View/download PDF
14. Neurogenesis in the human hippocampus and its relevance to temporal lobe epilepsies
- Author
-
Siebzehnrubl, Florian A. and Blumcke, Ingmar
- Published
- 2008
15. Identifying subpopulations in multicellular systems by quantitative chemical imaging using label-free hyperspectral CARS microscopy.
- Author
-
Pope, Iestyn, Masia, Francesco, Ewan, Kenneth, Jimenez-Pascual, Ana, Dale, Trevor C., Siebzehnrubl, Florian A., Borri, Paola, and Langbein, Wolfgang
- Subjects
IMAGING systems in chemistry ,ANTI-Stokes scattering ,AUTOMOBILES ,MICROSCOPY ,RAMAN microscopy ,CANCER stem cells - Abstract
Quantitative hyperspectral coherent Raman scattering microscopy merges imaging with spectroscopy and utilises quantitative data analysis algorithms to extract physically meaningful chemical components, spectrally and spatially-resolved, with sub-cellular resolution. This label-free non-invasive method has the potential to significantly advance our understanding of the complexity of living multicellular systems. Here, we have applied an in-house developed hyperspectral coherent anti-Stokes Raman scattering (CARS) microscope, combined with a quantitative data analysis pipeline, to imaging living mouse liver organoids as well as fixed mouse brain tissue sections xenografted with glioblastoma cells. We show that the method is capable of discriminating different cellular sub-populations, on the basis of their chemical content which is obtained from an unsupervised analysis, i.e. without prior knowledge. Specifically, in the organoids, we identify sub-populations of cells at different phases in the cell cycle, while in the brain tissue, we distinguish normal tissue from cancer cells, and, notably, tumours derived from transplanted cancer stem cells versus non-stem glioblastoma cells. The ability of the method to identify different sub-populations was validated by correlative fluorescence microscopy using fluorescent protein markers. These examples expand the application portfolio of quantitative chemical imaging by hyperspectral CARS microscopy to multicellular systems of significant biomedical relevance, pointing the way to new opportunities in non-invasive disease diagnostics. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
16. Metabolic heterogeneity and adaptability in brain tumors.
- Author
-
Badr, Christian E., Silver, Daniel J., Siebzehnrubl, Florian A., and Deleyrolle, Loic P.
- Subjects
BRAIN tumors ,CANCER stem cells ,HETEROGENEITY ,TREATMENT effectiveness ,TUMOR microenvironment - Abstract
The metabolic complexity and flexibility commonly observed in brain tumors, especially glioblastoma, is fundamental for their development and progression. The ability of tumor cells to modify their genetic landscape and adapt metabolically, subverts therapeutic efficacy, and inevitably instigates therapeutic resistance. To overcome these challenges and develop effective therapeutic strategies targeting essential metabolic processes, it is necessary to identify the mechanisms underlying heterogeneity and define metabolic preferences and liabilities of malignant cells. In this review, we will discuss metabolic diversity in brain cancer and highlight the role of cancer stem cells in regulating metabolic heterogeneity. We will also highlight potential therapeutic modalities targeting metabolic vulnerabilities and examine how intercellular metabolic signaling can shape the tumor microenvironment. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
17. Targeting the Ubiquitin System in Glioblastoma.
- Author
-
Scholz, Nico, Kurian, Kathreena M., Siebzehnrubl, Florian A., and Licchesi, Julien D. F.
- Subjects
UBIQUITIN ,GLIOBLASTOMA multiforme ,UBIQUITIN ligases ,SMALL molecules ,SURGICAL excision ,BRAIN tumors ,OLIGODENDROGLIOMAS - Abstract
Glioblastoma is the most common primary brain tumor in adults with poor overall outcome and 5-year survival of less than 5%. Treatment has not changed much in the last decade or so, with surgical resection and radio/chemotherapy being the main options. Glioblastoma is highly heterogeneous and frequently becomes treatment-resistant due to the ability of glioblastoma cells to adopt stem cell states facilitating tumor recurrence. Therefore, there is an urgent need for novel therapeutic strategies. The ubiquitin system, in particular E3 ubiquitin ligases and deubiquitinating enzymes, have emerged as a promising source of novel drug targets. In addition to conventional small molecule drug discovery approaches aimed at modulating enzyme activity, several new and exciting strategies are also being explored. Among these, PROteolysis TArgeting Chimeras (PROTACs) aim to harness the endogenous protein turnover machinery to direct therapeutically relevant targets, including previously considered "undruggable" ones, for proteasomal degradation. PROTAC and other strategies targeting the ubiquitin proteasome system offer new therapeutic avenues which will expand the drug development toolboxes for glioblastoma. This review will provide a comprehensive overview of E3 ubiquitin ligases and deubiquitinating enzymes in the context of glioblastoma and their involvement in core signaling pathways including EGFR, TGF-β, p53 and stemness-related pathways. Finally, we offer new insights into how these ubiquitin-dependent mechanisms could be exploited therapeutically for glioblastoma. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
18. ADAMDEC1 and FGF2/FGFR1 signaling constitute a positive feedback loop to maintain GBM cancer stem cells.
- Author
-
Jimenez-Pascual, Ana, Lathia, Justin D., and Siebzehnrubl, Florian A.
- Subjects
CANCER stem cells ,FIBROBLAST growth factor 2 ,METALLOPROTEINASES ,FIBROBLAST growth factors ,AUTOCRINE mechanisms - Abstract
Identification of targetable mechanisms that maintain glioblastoma cancer stem cells (CSCs) remain a priority. Our study reveals a new mechanism by which a disintegrin and metalloproteinase domain-like protein decysin 1 promotes CSC maintenance through the activation of a fibroblast growth factor autocrine signaling loop, which can be blocked pharmacologically. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
19. Singular Adult Neural Stem Cells Do Not Exist.
- Author
-
Petrik, David, Jörgensen, Sara, Eftychidis, Vasileios, and Siebzehnrubl, Florian A.
- Subjects
NEURAL stem cells ,PROGENITOR cells ,STEM cells ,ADULTS ,GENETIC models ,FATE mapping (Genetics) - Abstract
Adult neural stem cells (aNSCs) are the source for the continuous production of new neurons throughout life. This so-called adult neurogenesis has been extensively studied; the intermediate cellular stages are well documented. Recent discoveries have raised new controversies in the field, such as the notion that progenitor cells hold similar self-renewal potential as stem cells, or whether different types of aNSCs exist. Here, we discuss evidence for heterogeneity of aNSCs, including short-term and long-term self-renewing aNSCs, regional and temporal differences in aNSC function, and single cell transcriptomics. Reviewing various genetic mouse models used for targeting aNSCs and lineage tracing, we consider potential lineage relationships between Ascl1-, Gli1-, and Nestin-targeted aNSCs. We present a multidimensional model of adult neurogenesis that incorporates recent findings and conclude that stemness is a phenotype, a state of properties that can change with time, rather than a cell property, which is static and immutable. We argue that singular aNSCs do not exist. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
20. Increased Precursor Cell Proliferation after Deep Brain Stimulation for Parkinson's Disease: A Human Study.
- Author
-
Vedam-Mai, Vinata, Gardner, Bronwen, Okun, Michael S., Siebzehnrubl, Florian A., Kam, Monica, Aponso, Palingu, Steindler, Dennis A., Yachnis, Anthony T., Neal, Dan, Oliver, Brittany U., Rath, Sean J., Faull, Richard L. M., Reynolds, Brent A., and Curtis, Maurice A.
- Subjects
CELL proliferation ,BRAIN stimulation ,PARKINSON'S disease ,BIOCHEMICAL mechanism of action ,IMMUNOHISTOCHEMISTRY ,SYMPTOMS ,MATERIAL plasticity - Abstract
Objective: Deep brain stimulation (DBS) has been used for more than a decade to treat Parkinson's disease (PD); however, its mechanism of action remains unknown. Given the close proximity of the electrode trajectory to areas of the brain known as the “germinal niches,” we sought to explore the possibility that DBS influences neural stem cell proliferation locally, as well as more distantly. Methods: We studied the brains of a total of 12 idiopathic Parkinson's disease patients that were treated with DBS (the electrode placement occurred 0.5–6 years before death), and who subsequently died of unrelated illnesses. These were compared to the brains of 10 control individuals without CNS disease, and those of 5 PD patients with no DBS. Results: Immunohistochemical analyses of the subventricular zone (SVZ) of the lateral ventricles, the third ventricle lining, and the tissue surrounding the DBS lead revealed significantly greater numbers of proliferating cells expressing markers of the cell cycle, plasticity, and neural precursor cells in PD-DBS tissue compared with both normal brain tissue and tissue from PD patients not treated with DBS. The level of cell proliferation in the SVZ in PD-DBS brains was 2–6 fold greater than that in normal and untreated PD brains. Conclusions: Our data suggest that DBS is capable of increasing cellular plasticity in the brain, and we hypothesize that it may have more widespread effects beyond the electrode location. It is unclear whether these effects of DBS have any symptomatic or other beneficial influences on PD. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
21. Chondroitin Sulfate Proteoglycans Potently Inhibit Invasion and Serve as a Central Organizer of the Brain Tumor Microenvironment.
- Author
-
Silver, Daniel J., Siebzehnrubl, Florian A., Schildts, Michela J., Yachnis, Anthony T., Smith, George M., Smith, Amy A., Scheffler, Bjorn, Reynolds, Brent A., Silver, Jerry, and Steindler, Dennis A.
- Subjects
- *
CHONDROITIN sulfates , *PROTEOGLYCANS , *BRAIN tumors , *GLIOBLASTOMA multiforme , *EXTRACELLULAR matrix , *CHONDROITIN sulfate proteoglycan , *PHOSPHATASES , *DIAGNOSIS - Abstract
Glioblastoma (GBM) remains the most pervasive and lethal of all brain malignancies. One factor that contributes to this poor prognosis is the highly invasive character of the tumor. GBM is characterized by microscopic infiltration of tumor cells throughout the brain, whereas non-neural metastases, as well as select lower grade gliomas, develop as self-contained and clearly delineated lesions. Illustrated by rodent xenograft tumor models as well as pathological human patient specimens, we present evidence that one fundamental switch between these two distinct pathologies-invasion and noninvasion-is mediated through the tumor extracellular matrix. Specifically, noninvasive lesions are associated with a rich matrix containing substantial amounts of glycosylated chondroitin sulfate proteoglycans (CSPGs), whereas glycosylated CSPGs are essentially absent from diffusely infiltrating tumors. CSPGs, acting as central organizers of the tumor microenvironment, dramatically influence resident reactive astrocytes, inducing their exodus from the tumor mass and the resultant encapsulation of noninvasive lesions. Additionally, CSPGs induce activation of tumor-associated microglia. We demonstrate that the astrogliotic capsule can directly inhibit tumor invasion, and its absence from GBM presents an environment favorable to diffuse infiltration. We also identify the leukocyte common antigen-related phosphatase receptor (PTPRF) as a putative intermediary between extracellular glycosylated CSPGs and noninvasive tumor cells. In all, we present CSPGs as critical regulators of brain tumor histopathology and help to clarify the role of the tumor microenvironment in brain tumor invasion. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
22. Mesenchymal Stem Cells Promote Oligodendroglial Differentiation in Hippocampal Slice Cultures.
- Author
-
Rivera, Francisco J., Siebzehnrubl, Florian A., Kandasamy, Mahesh, Couillard-Despres, Sebastien, Caioni, Massimiliano, Poehler, Anne-Maria, Berninger, Benedikt, Sandner, Beatrice, Bogdahn, Ulrich, Goetz, Magdalena, Bluemcke, Ingmar, Weidner, Norbert, and Aigner, Ludwig
- Subjects
- *
MESENCHYME , *STEM cells , *MULTIPLE sclerosis , *LABORATORY rats , *HIPPOCAMPUS (Brain) - Abstract
We have previously shown that soluble factors derived from mesenchymal stem cells (MSCs) induce oligodendrogenic fate and differentiation in adult rat neural progenitors (NPCs) in vitro. Here, we investigated if this pro-oligodendrogenic effect is maintained after cells have been transplanted onto rat hippocampal slice cultures, a CNS-organotypic environment. We first tested whether NPCs, that were pre-differentiated in vitro by MSC-derived conditioned medium, would generate oligodendrocytes after transplantation. This approach resulted in the loss of grafted NPCs, suggesting that oligodendroglial pre-differentiated cells could not integrate in the tissue and therefore did not survive grafting. However, when NPCs together with MSCs were transplanted in situ into hippocampal slice cultures, the grafted NPCs survived and the majority of them differentiated into oligodendrocytes. In contrast to the prevalent oligodendroglial differentiation in case of the NPC/MSC co-transplantation, naïve NPCs transplanted in the absence of MSCs differentiated predominantly into astrocytes. In summary, the pro-oligodendrogenic activity of MSCs was maintained only after co-transplantation into hippocampal slice cultures. Therefore, in the otherwise astrogenic milieu, MSCs established an oligodendrogenic niche for transplanted NPCs, and thus, co-transplantation of MSCs with NPCs might provide an attractive approach to re-myelinate the various regions of the diseased CNS. Copyright © 2009 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
23. The Stem Cell Marker Prominin-1/CD133 on Membrane Particles in Human Cerebrospinal Fluid Offers Novel Approaches for Studying Central Nervous System Disease.
- Author
-
Huttner, Hagen B., Janich, Peggy, Köhrmann, Martin, Jászai, József, Siebzehnrubl, Florian, Blümcke, Ingmar, Suttorp, Meinolf, Gahr, Manfred, Kuhnt, Daniela, Nimsky, Christopher, Krex, Dietmar, Schackert, Gabriele, Löwenbrück, Kai, Reichmann, Heinz, Jüttler, Eric, Hacke, Werner, Schellinger, Peter D., Schwab, Stefan, Wilsch-Bräuninger, Michaela, and Marzesco, Anne-Marie
- Subjects
GLIOMAS ,NERVOUS system tumors ,NERVOUS system ,HEMATOPOIETIC stem cells ,BONE marrow cells - Abstract
Cerebrospinal fluid (CSF) is routinely used for diagnosing and monitoring neurological diseases. The CSF proteins used so far for diagnostic purposes (except for those associated with whole cells) are soluble. Here, we show that human CSF contains specific membrane particles that carry prominin- 1/CD133, a neural stem cell marker implicated in brain tumors, notably glioblastoma. Differential and equilibrium centrifugation and detergent solubility analyses showed that these membrane particles were similar in physical properties and microdomain organization to small membrane vesicles previously shown to be released from neural stem cells in the mouse embryo. The levels of membrane particle-associated prominin-1/CD133 declined during childhood and remained constant thereafter, with a remarkably narrow range in healthy adults. Glioblastoma patients showed elevated levels of membrane particle- associated prominin-1/CD133, which decreased dramatically in the final stage of the disease. Hence, analysis of CSF for membrane particles carrying the somatic stem cell marker prominin-1/CD133 offers a novel approach for studying human central nervous system disease. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
24. The transcription factor ZEB1 regulates stem cell self-renewal and cell fate in the adult hippocampus.
- Author
-
Gupta, Bhavana, Errington, Adam C., Jimenez-Pascual, Ana, Eftychidis, Vasileios, Brabletz, Simone, Stemmler, Marc P., Brabletz, Thomas, Petrik, David, and Siebzehnrubl, Florian A.
- Abstract
Radial glia-like (RGL) stem cells persist in the adult mammalian hippocampus, where they generate new neurons and astrocytes throughout life. The process of adult neurogenesis is well documented, but cell-autonomous factors regulating neuronal and astroglial differentiation are incompletely understood. Here, we evaluate the functions of the transcription factor zinc-finger E-box binding homeobox 1 (ZEB1) in adult hippocampal RGL cells using a conditional-inducible mouse model. We find that ZEB1 is necessary for self-renewal of active RGL cells. Genetic deletion of Zeb1 causes a shift toward symmetric cell division that consumes the RGL cell and generates pro-neuronal progenies, resulting in an increase of newborn neurons and a decrease of newly generated astrocytes. We identify ZEB1 as positive regulator of the ets-domain transcription factor ETV5 that is critical for asymmetric division. [Display omitted] • The stem cell transcription factor, ZEB1, demarcates active from quiescent RGL cells • ZEB1 drives the self-renewal of RGL cells by promoting asymmetric cell division • Loss of Zeb1 causes increased neurogenesis and decreased astrogliogenesis • ZEB1 induces Etv5 expression to regulate asymmetric cell division Gupta et al. show that the stem cell transcription factor, ZEB1, labels activated hippocampal stem cells and regulates their self-renewal and astroglial fate specification. Mechanistically, ZEB1 promotes asymmetric cell divisions and induces the expression of ETV5, a transcriptional regulator of asymmetric divisions and astroglial lineage commitment. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
25. HiSpots®: A novel ex vivo patient-derived 3D model of glioblastoma.
- Author
-
Brown, Jo, Zaben, Malik, Siebzehnrubl, Florian, and Gray, William P
- Published
- 2019
- Full Text
- View/download PDF
26. The metalloproteinase ADAMDEC1 maintains a novel growth factor signalling loop in glioblastoma cancer stem cells.
- Author
-
Jimenez-Pascual, Ana, Hale, James, Kordowski, Anja, Pugh, Jamie, Rao, Shilpa, Silver, Daniel, Alban, Tyler, Watson, Defne, Chen, Rui, McIntyre, Thomas, Colombo, Giorgio, Taraboletti, Giulia, Holmberg, Karl, Forsberg-Nilsson, Karin, Lathia, Justin, and Siebzehnrubl, Florian
- Published
- 2019
- Full Text
- View/download PDF
27. Fibroblast Growth Factor Receptor Functions in Glioblastoma.
- Author
-
Jimenez-Pascual, Ana and A. Siebzehnrubl, Florian
- Subjects
- *
FIBROBLAST growth factor receptors , *FIBROBLAST growth factors - Abstract
Glioblastoma is the most lethal brain cancer in adults, with no known cure. This cancer is characterized by a pronounced genetic heterogeneity, but aberrant activation of receptor tyrosine kinase signaling is among the most frequent molecular alterations in glioblastoma. Somatic mutations of fibroblast growth factor receptors (FGFRs) are rare in these cancers, but many studies have documented that signaling through FGFRs impacts glioblastoma progression and patient survival. Small-molecule inhibitors of FGFR tyrosine kinases are currently being trialed, underlining the therapeutic potential of blocking this signaling pathway. Nevertheless, a comprehensive overview of the state of the art of the literature on FGFRs in glioblastoma is lacking. Here, we review the evidence for the biological functions of FGFRs in glioblastoma, as well as pharmacological approaches to targeting these receptors. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
28. Infiltrative and drug‐resistant slow‐cycling cells support metabolic heterogeneity in glioblastoma.
- Author
-
Hoang‐Minh, Lan B, Siebzehnrubl, Florian A, Yang, Changlin, Suzuki‐Hatano, Silveli, Dajac, Kyle, Loche, Tyler, Andrews, Nicholas, Schmoll Massari, Michael, Patel, Jaimin, Amin, Krisha, Vuong, Alvin, Jimenez‐Pascual, Ana, Kubilis, Paul, Garrett, Timothy J, Moneypenny, Craig, Pacak, Christina A, Huang, Jianping, Sayour, Elias J, Mitchell, Duane A, and Sarkisian, Matthew R
- Subjects
- *
GLIOBLASTOMA multiforme , *MITOCHONDRIAL DNA , *OXIDATIVE phosphorylation , *GLYCOLYSIS , *CANCER chemotherapy - Abstract
Metabolic reprogramming has been described in rapidly growing tumors, which are thought to mostly contain fast‐cycling cells (FCCs) that have impaired mitochondrial function and rely on aerobic glycolysis. Here, we characterize the metabolic landscape of glioblastoma (GBM) and explore metabolic specificities as targetable vulnerabilities. Our studies highlight the metabolic heterogeneity in GBM, in which FCCs harness aerobic glycolysis, and slow‐cycling cells (SCCs) preferentially utilize mitochondrial oxidative phosphorylation for their functions. SCCs display enhanced invasion and chemoresistance, suggesting their important role in tumor recurrence. SCCs also demonstrate increased lipid contents that are specifically metabolized under glucose‐deprived conditions. Fatty acid transport in SCCs is targetable by pharmacological inhibition or genomic deletion of FABP7, both of which sensitize SCCs to metabolic stress. Furthermore, FABP7 inhibition, whether alone or in combination with glycolysis inhibition, leads to overall increased survival. Our studies reveal the existence of GBM cell subpopulations with distinct metabolic requirements and suggest that FABP7 is central to lipid metabolism in SCCs and that targeting FABP7‐related metabolic pathways is a viable therapeutic strategy. Synopsis: Transcriptomic and metabolomic profiling of primary brain tumor cells demonstrate that functionally different glioblastoma (GBM) cell subpopulations depend on distinct metabolic pathways for their growth and survival. More invasive slow cycling tumor cells rely on oxidative phosphorylation and lipid metabolism, suggesting targetable candidates for the inhibition of treatment‐resistant tumors. Patient‐derived GBM cells contain fast‐cycling cells (FCCs) relying on aerobic glycolysis and slow‐cycling cells (SCCs) depending on mitochondrial oxidative phosphorylation in vivo.SCCs show increased resistance, invasion, and metabolic gene signatures characteristic of recurrent tumors.SCCs show increased levels of metabolites and components involved in lipid metabolism, storage, and transport.Block of FABP7‐dependent exogenous fatty acid uptake decreases resistance of SCCs to chemotherapy and glucose deprivation. Oxidative phosphorylation and lipid metabolism specify distinct energetic set‐up of invasive brain tumor cells. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
29. Neurogenic potential of progenitor cells isolated from postmortem human Parkinsonian brains
- Author
-
Wang, Shanshan, Okun, Michael S., Suslov, Oleg, Zheng, Tong, McFarland, Nikolaus R., Vedam-Mai, Vinata, Foote, Kelly D., Roper, Steven N., Yachnis, Anthony T., Siebzehnrubl, Florian A., and Steindler, Dennis A.
- Subjects
- *
NEUROLOGY , *ELECTROPHYSIOLOGY , *ACTION potentials , *PROGENITOR cells , *PARKINSON'S disease , *CELLULAR therapy - Abstract
Abstract: The success of cellular therapies for Parkinson''s disease (PD) will depend not only on a conducive growth environment in vivo, but also on the ex vivo amplification and targeted neural differentiation of stem/progenitor cells. Here, we demonstrate the in vitro proliferative and differentiation potential of stem/progenitor cells, adult human neural progenitor cells (“AHNPs”) isolated from idiopathic PD postmortem tissue samples and, to a lesser extent, discarded deep brain stimulation electrodes. We demonstrate that these AHNPs can be isolated from numerous structures (e.g. substantia nigra, “SN”) and are able to differentiate into both glia and neurons, but only under particular growth conditions including co-culturing with embryonic stem cell-derived neural precursors (“ESNPs”); this suggests that PD multipotent neural stem/progenitor cells do reside within the SN and other areas, but by themselves appear to lack key factors required for neuronal differentiation. AHNPs engraft following ex vivo expansion and transplantation into the rodent brain, demonstrating their regenerative potential. Our data demonstrate the presence and capacity of endogenous stem/progenitor cells in the PD brain. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.